Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 50

References for PMC Articles for PubMed (Select 20593015)

1.

International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials.

Mast TC, Kierstead L, Gupta SB, Nikas AA, Kallas EG, Novitsky V, Mbewe B, Pitisuttithum P, Schechter M, Vardas E, Wolfe ND, Aste-Amezaga M, Casimiro DR, Coplan P, Straus WL, Shiver JW.

Vaccine. 2010 Jan 22;28(4):950-7. doi: 10.1016/j.vaccine.2009.10.145. Epub 2009 Nov 17.

PMID:
19925902
2.

Isolation and characterization of adenoviruses persistently shed from the gastrointestinal tract of non-human primates.

Roy S, Vandenberghe LH, Kryazhimskiy S, Grant R, Calcedo R, Yuan X, Keough M, Sandhu A, Wang Q, Medina-Jaszek CA, Plotkin JB, Wilson JM.

PLoS Pathog. 2009 Jul;5(7):e1000503. doi: 10.1371/journal.ppat.1000503. Epub 2009 Jul 3.

3.

Failure of the Merck HIV vaccine: an uncertain step forward.

Robb ML.

Lancet. 2008 Nov 29;372(9653):1857-8. doi: 10.1016/S0140-6736(08)61593-7. Epub 2008 Nov 13. No abstract available.

PMID:
19012958
4.

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.

Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, Gilbert PB, Lama JR, Marmor M, Del Rio C, McElrath MJ, Casimiro DR, Gottesdiener KM, Chodakewitz JA, Corey L, Robertson MN; Step Study Protocol Team.

Lancet. 2008 Nov 29;372(9653):1881-93. doi: 10.1016/S0140-6736(08)61591-3. Epub 2008 Nov 13.

5.

Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells.

Perreau M, Pantaleo G, Kremer EJ.

J Exp Med. 2008 Nov 24;205(12):2717-25. doi: 10.1084/jem.20081786. Epub 2008 Nov 3.

6.

Adenoviruses in immunocompromised hosts.

Echavarría M.

Clin Microbiol Rev. 2008 Oct;21(4):704-15. doi: 10.1128/CMR.00052-07. Review.

7.

Development of multiplexed real-time quantitative polymerase chain reaction assay for detecting human adenoviruses.

Huang ML, Nguy L, Ferrenberg J, Boeckh M, Cent A, Corey L.

Diagn Microbiol Infect Dis. 2008 Nov;62(3):263-71. doi: 10.1016/j.diagmicrobio.2008.06.009. Epub 2008 Aug 15.

8.

Impact of recombinant adenovirus serotype 35 priming versus boosting of a Plasmodium falciparum protein: characterization of T- and B-cell responses to liver-stage antigen 1.

Rodríguez A, Goudsmit J, Companjen A, Mintardjo R, Gillissen G, Tax D, Sijtsma J, Weverling GJ, Holterman L, Lanar DE, Havenga MJ, Radosevic K.

Infect Immun. 2008 Apr;76(4):1709-18. doi: 10.1128/IAI.01614-07. Epub 2008 Jan 22.

9.

Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.

Zuckerman RA, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, Zuñiga R, Magaret AS, Wald A, Corey L, Celum C.

J Infect Dis. 2007 Nov 15;196(10):1500-8. Epub 2007 Oct 31.

10.

Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004-2006.

Gray GC, McCarthy T, Lebeck MG, Schnurr DP, Russell KL, Kajon AE, Landry ML, Leland DS, Storch GA, Ginocchio CC, Robinson CC, Demmler GJ, Saubolle MA, Kehl SC, Selvarangan R, Miller MB, Chappell JD, Zerr DM, Kiska DL, Halstead DC, Capuano AW, Setterquist SF, Chorazy ML, Dawson JD, Erdman DD.

Clin Infect Dis. 2007 Nov 1;45(9):1120-31. Epub 2007 Sep 27.

11.

Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon.

Radosevic K, Wieland CW, Rodriguez A, Weverling GJ, Mintardjo R, Gillissen G, Vogels R, Skeiky YA, Hone DM, Sadoff JC, van der Poll T, Havenga M, Goudsmit J.

Infect Immun. 2007 Aug;75(8):4105-15. Epub 2007 May 25.

12.

MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0.

Tamura K, Dudley J, Nei M, Kumar S.

Mol Biol Evol. 2007 Aug;24(8):1596-9. Epub 2007 May 7.

13.

Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D.

Abbink P, Lemckert AA, Ewald BA, Lynch DM, Denholtz M, Smits S, Holterman L, Damen I, Vogels R, Thorner AR, O'Brien KL, Carville A, Mansfield KG, Goudsmit J, Havenga MJ, Barouch DH.

J Virol. 2007 May;81(9):4654-63. Epub 2007 Feb 28.

14.

Age dependence of adenovirus-specific neutralizing antibody titers in individuals from sub-Saharan Africa.

Thorner AR, Vogels R, Kaspers J, Weverling GJ, Holterman L, Lemckert AA, Dilraj A, McNally LM, Jeena PM, Jepsen S, Abbink P, Nanda A, Swanson PE, Bates AT, O'Brien KL, Havenga MJ, Goudsmit J, Barouch DH.

J Clin Microbiol. 2006 Oct;44(10):3781-3.

15.

Molecular typing of human adenoviruses by PCR and sequencing of a partial region of the hexon gene.

Lu X, Erdman DD.

Arch Virol. 2006 Aug;151(8):1587-602. Epub 2006 Feb 26.

PMID:
16502282
16.

Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.

Hoelscher MA, Garg S, Bangari DS, Belser JA, Lu X, Stephenson I, Bright RA, Katz JM, Mittal SK, Sambhara S.

Lancet. 2006 Feb 11;367(9509):475-81.

17.
18.

Evidence for persistence of adenovirus in the tear film a decade following conjunctivitis.

Kaye SB, Lloyd M, Williams H, Yuen C, Scott JA, O'Donnell N, Batterbury M, Hiscott P, Hart CA.

J Med Virol. 2005 Oct;77(2):227-31.

PMID:
16121360
19.

Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunity.

Lemckert AA, Sumida SM, Holterman L, Vogels R, Truitt DM, Lynch DM, Nanda A, Ewald BA, Gorgone DA, Lifton MA, Goudsmit J, Havenga MJ, Barouch DH.

J Virol. 2005 Aug;79(15):9694-701.

20.

Longitudinal observation of enterovirus and adenovirus in stool samples from Norwegian infants with the highest genetic risk of type 1 diabetes.

Cinek O, Witsø E, Jeansson S, Rasmussen T, Drevinek P, Wetlesen T, Vavrinec J, Grinde B, Rønningen KS.

J Clin Virol. 2006 Jan;35(1):33-40.

PMID:
15916916
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk